coronavirus vaccine

Facebook recently announced that they would ban any advertisement that portrays COVID-19 vaccines as unsafe or ineffective. The CEO of the Center for Countering Digital Hate, Imran Ahmed, explains how social media companies have profited from this misinformation.

A group of scientific advisers say they’re concerned that the U.S. government’s plans to expedite COVID-19 vaccines could damage public confidence in the shots

Dr. Chris Pernell, a New Jersey public health physician, became a patient in Moderna’s COVID-19 vaccine trial after she lost her father to the virus. She joins LX News to discuss why it was important for her to join the trial to honor her father and to advocate for better health care for Black and brown communities that have suffered...

Volunteers in the United Kingdom look set to be intentionally infected with Covid-19 as part of an experimental trial that could change scientists’ understanding of the virus, NBC News reports.

More than 10,000 of the new hires will be full-time and part-time pharmacy technicians who can help dispense medications and administer COVID-19 tests.

Healthy young people might not get the coronavirus vaccine until 2022 as public health officials focus on immunizing the elderly and other vulnerable groups first, top officials from the World Health Organization said Wednesday. Dr. Soumya Swaminathan, WHO’s chief scientist, said health workers, frontline workers and the elderly will likely be offered a vaccine first, though prioritization details are still…

The company said it had paused clinical trials following an “unexplained” patient illness.

Companies and governments around the world are testing at least 120 potential vaccines for COVID-19. One of the test subjects is a local scientist.

The head of Pfizer, one of the drugmakers racing to develop a coronavirus vaccine, told employees he was disappointed that its work was politicized during this week’s presidential debate and tried to reassure U.S. staff that the company won’t bend to pressure to move more quickly

The COVAX facility is a global effort to find, develop and distribute a safe, effective coronavirus vaccine to every country in the world. But the U.S. has declined to participate due to President Trump’s lack of confidence in the World Health Organization. But can an America-first strategy for vaccine development work? The New York Times takes a closer look....

Hundreds of thousands of people have taken one of the four leading vaccine candidates in China

Writer Molly Jong-Fast walks us through her experience of participating in a COVID-19 vaccine trial, why she did it, and why you are much safer taking the vaccine than taking your chances of contracting the virus.

A fourth COVID-19 vaccine candidate has gone into the final stage of clinical trials in the U.S., with Johnson & Johnson announcing the start of its Phase 3 trial Wednesday, NBC News reports.

As pharmaceutical companies race to manufacture a COVID-19 vaccine, many people are wary of a shot that is working its way through the approval process at record speed during a highly politicized pandemic, NBC News reports. While some professions could require employees to get the vaccine, experts say schools almost certainly will require students to — potentially setting the stage...

The president of Xavier University of Louisiana, Reynold Verret, is participating in a Covid-19 vaccine trial and encouraging Black students to follow suit. He explains why it is so important for people of color to be represented in the vaccine trials given that they are disproportionately dying from the virus.

Companies are struggling to recruit diverse volunteers in final U.S. tests of possible COVID-19 vaccines

With the country fast approaching 200,000 deaths due to COVID-19, our nation is in desperate need of a vaccine. Dr. Tom Frieden was the CDC Director under the Obama Administration and is outlining all the hurdles required for a COVID-19 vaccine to be cleared.

Moderna should have enough data from its late-stage trial to know whether its coronavirus vaccine works in November, CEO Stephane Bancel said Thursday.  The company could have enough data by October, but that’s unlikely, Bancel said during an interview on CNBC’s “Squawk Box.” “If the infection rate in the country were to slow down in the next weeks, it could potentially be...

Pfizer’s coronavirus vaccine could be distributed to Americans before the end of the year if found to be safe and effective, CEO Albert Bourla said Sunday.

Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K.